Literature DB >> 30177017

Genetic Determinants of IgA Nephropathy: Eastern Perspective.

Ming Li1, Xue-Qing Yu2.   

Abstract

IgA nephropathy (IgAN) is one of the most common primary glomerulonephritides throughout the world and a major cause of end-stage renal disease among the East Asian population. It is widely considered that genetic factors play an important role in the pathogenesis of IgAN. This article summarizes the recent achievements in the genetic studies of IgAN, focusing mainly on studies performed in East Asia, from the early association studies of candidate genes and family based designs, to the recent genome-wide association studies. There have been five large genome-wide association studies performed that have identified multiple susceptibility loci for IgAN, especially some novel loci identified in the Chinese population. Genes within these loci have provided important insights into the potential biological mechanisms and pathways that influence genetic risk to IgAN. In susceptibility loci/genes, the study of genetic interaction and structural variants (such as copy number variation) was conducted to identify more variants associated with IgAN and disease progression. Genetic studies of IgAN from East Asia have made great achievements over the years. Most susceptibility loci discovered to date encode genes involved in the response to mucosal pathogens, suggesting that an intestinal-immune network for IgA production may be involved in the pathogenesis of IgAN. Although genetic studies of the complex diseases are challenging, for future genetic studies in IgAN, new genetic techniques and methods of analysis, especially next-generation sequencing, need to be applied to push the genetic studies forward.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IgA nephropathy (IgAN); common variants; copy number variants (CNV); genome-wide association study (GWAS); rare variants

Mesh:

Year:  2018        PMID: 30177017     DOI: 10.1016/j.semnephrol.2018.05.015

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  6 in total

1.  Differentiation of T Helper 17 Cells May Mediate the Abnormal Humoral Immunity in IgA Nephropathy and Inflammatory Bowel Disease Based on Shared Genetic Effects.

Authors:  Jianbo Qing; Changqun Li; Xueli Hu; Wenzhu Song; Hasna Tirichen; Hasnaa Yaigoub; Yafeng Li
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

2.  Exome Chip Analyses and Genetic Risk for IgA Nephropathy among Han Chinese.

Authors:  Xu-Jie Zhou; Lam C Tsoi; Yong Hu; Matthew T Patrick; Kevin He; Celine C Berthier; Yanming Li; Yan-Na Wang; Yuan-Yuan Qi; Yue-Miao Zhang; Ting Gan; Yang Li; Ping Hou; Li-Jun Liu; Su-Fang Shi; Ji-Cheng Lv; Hu-Ji Xu; Hong Zhang
Journal:  Clin J Am Soc Nephrol       Date:  2021-01-18       Impact factor: 8.237

3.  Validation of an international prediction model including the Oxford classification in Korean patients with IgA nephropathy.

Authors:  Dohui Hwang; Kyoungjin Choi; Nam-Jun Cho; Samel Park; Byung Chul Yu; Hyo-Wook Gil; Eun Young Lee; Soo Jeong Choi; Moo Yong Park; Jin Kuk Kim; Seung Duk Hwang; Soon Hyo Kwon; Jin Seok Jeon; Hyunjin Noh; Dong Cheol Han; Hyoungnae Kim
Journal:  Nephrology (Carlton)       Date:  2021-03-03       Impact factor: 2.506

Review 4.  The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy.

Authors:  Dana V Rizk; Nicolas Maillard; Bruce A Julian; Barbora Knoppova; Todd J Green; Jan Novak; Robert J Wyatt
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

5.  New susceptible locus, rs9428555, is associated with pediatric-onset immunoglobulin A nephropathy and immunoglobulin A vasculitis in Koreans.

Authors:  Minho Lee; Gunhee Lee; Hee Gyung Kang; Jin-Soon Suh
Journal:  Genes Genomics       Date:  2021-06-19       Impact factor: 1.839

6.  ST6Gal1 is up-regulated and associated with aberrant IgA1 glycosylation in IgA nephropathy: An integrated analysis of the transcriptome.

Authors:  Youxia Liu; Fanghao Wang; Yaru Zhang; Junya Jia; Tiekun Yan
Journal:  J Cell Mol Med       Date:  2020-07-17       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.